Literature DB >> 27659465

Plasma NGAL: So, it Really Is Just Expensive Creatinine!

Jeffrey M Testani1, Meredith A Brisco2.   

Abstract

Entities:  

Keywords:  NGAL; cardiorenal syndrome; worsening renal function

Mesh：

Substances：

Year:  2016        PMID： 27659465      PMCID： PMC5497471          DOI： 10.1016/j.jacc.2016.07.730

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  13 in total

1.  Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury--where do we stand today?

Authors:  Kai M Schmidt-Ott
Journal:  Nephrol Dial Transplant       Date:  2011-02-09       Impact factor: 5.992

Review 2.  Novel renal biomarkers to assess cardiorenal syndrome.

Authors:  Meredith A Brisco; Jeffrey M Testani
Journal:  Curr Heart Fail Rep       Date:  2014-12

3.  Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.

Authors:  Margarida Alvelos; Rodrigo Pimentel; Elika Pinho; André Gomes; Patricia Lourenço; Maria José Teles; Pedro Almeida; João Tiago Guimarães; Paulo Bettencourt
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 8.237

4.  Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction.

Authors:  Jeffrey M Testani; Stephen E Kimmel; Daniel L Dries; Steven G Coca
Journal:  Circ Heart Fail       Date:  2011-09-08       Impact factor: 8.790

5.  Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes.

Authors:  Jeffrey M Testani; Steven G Coca; Brian D McCauley; Richard P Shannon; Stephen E Kimmel
Journal:  Eur J Heart Fail       Date:  2011-06-21       Impact factor: 15.534

6.  Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.

Authors:  Arash Aghel; Kevin Shrestha; Wilfried Mullens; Allen Borowski; W H Wilson Tang
Journal:  J Card Fail       Date:  2009-08-21       Impact factor: 5.712

7.  Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study.

Authors:  Alan S Maisel; Nicholas Wettersten; Dirk J van Veldhuisen; Christian Mueller; Gerasimos Filippatos; Richard Nowak; Christopher Hogan; Michael C Kontos; Chad M Cannon; Gerhard A Müller; Robert Birkhahn; Paul Clopton; Pam Taub; Gary M Vilke; Kenneth McDonald; Niall Mahon; Julio Nuñez; Carlo Briguori; Claudio Passino; Patrick T Murray
Journal:  J Am Coll Cardiol       Date:  2016-09-27       Impact factor: 24.094

8.  Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure.

Authors:  Kevin Shrestha; Zhili Shao; Dhssraj Singh; Matthias Dupont; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2012-07-25       Impact factor: 2.778

Review 9.  Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.

Authors:  Kevin Damman; Mattia A E Valente; Adriaan A Voors; Christopher M O'Connor; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Eur Heart J       Date:  2013-10-27       Impact factor: 29.983

10.  Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.

Authors:  Meredith A Brisco; Michael R Zile; Jennifer S Hanberg; F Perry Wilson; Chirag R Parikh; Steven G Coca; W H Wilson Tang; Jeffrey M Testani
Journal:  J Card Fail       Date:  2016-06-30       Impact factor: 5.712
View more
  1 in total

1.  Renal and Inflammation Markers-Renalase, Cystatin C, and NGAL Levels in Asymptomatic and Symptomatic SARS-CoV-2 Infection in a One-Month Follow-Up Study.

Authors:  Natalia Serwin; Elżbieta Cecerska-Heryć; Ewa Pius-Sadowska; Karol Serwin; Anna Niedźwiedź; Magda Wiśniewska; Marta Roszak; Bartłomiej Grygorcewicz; Edyta Skwirczyńska; Bogusław Machaliński; Barbara Dołęgowska
Journal:  Diagnostics (Basel)       Date:  2022-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.